ALLMedicine™ Uterine Cancer Center

Apr 13th, 2021 - A recent paper suggested all women with endometrial cancer should take statins but it is unclear whether there is sufficient evidence to justify this recommendation. We identified all women diagnosed with uterine cancer in Australia between July 2...

Apr 9th, 2021 - Pelvic recurrences from previously irradiated gynecological cancer lack solid evidence for recommendation on salvage. A total of 58 patients were included in this clinical analysis. Salvage surgery was performed for locoregional relapse within pre...

Apr 2nd, 2021 - Wee1 Inhibition in Recurrent Serous Uterine Cancer: Science Paving the Way in a Challenging Disease.|2021|Madariaga A,Oza AM,|

Mar 16th, 2021 - Black women with uterine cancer on average have worse survival outcomes compared to White women, in part due to higher rates of aggressive, non-endometrioid subtypes. However, analyses of incidence trends by specific high-risk subtypes are lacking...

Mar 11th, 2021 - Cancer survivors are frequently excluded from clinical research, resulting in their omission from the development of many cancer treatment strategies. Quantifying the prevalence of prior cancer in newly diagnosed cancer patients can inform researc...

Feb 2nd, 2019 - Although cancer has historically been considered a disease of aging, a reported sharp rise in colorectal cancer incidence among adults aged 54 years and younger beginning in the mid-1980s for the colon and mid-1970s for the rectum has motivated re...

Feb 2nd, 2019 - Cancer trends in younger adults, often under 50 years, reflect recent changes in carcinogenic exposures, which could foreshadow the future overall disease burden. Previous studies reported an increase in early onset colorectal cancer, which could ...

Sep 2nd, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r.

Aug 23rd, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

Aug 23rd, 2017 - Ovarian cancer is the second most common type of female reproductive cancer, and more women die from ovarian cancer than from cervical cancer and uterine cancer combined. Currently, there is no strategy for early detection of ovarian cancer that r...

Apr 28th, 2021 - There is a risk that inpatients will be lost to follow-up if appointments are not made at the time of discharge, says the latest national report from England's Healthcare Safety Investigation Branch (HSIB). The report uses a reference case to demo...

Apr 13th, 2021 - A recent paper suggested all women with endometrial cancer should take statins but it is unclear whether there is sufficient evidence to justify this recommendation. We identified all women diagnosed with uterine cancer in Australia between July 2...

Apr 13th, 2021 - Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicate...

Apr 11th, 2021 - Medroxyprogesterone Acetate Tablets USP are indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as fibroids or uterine cancer. They are also indicate...

Apr 9th, 2021 - Pelvic recurrences from previously irradiated gynecological cancer lack solid evidence for recommendation on salvage. A total of 58 patients were included in this clinical analysis. Salvage surgery was performed for locoregional relapse within pre...

Apr 28th, 2021 - There is a risk that inpatients will be lost to follow-up if appointments are not made at the time of discharge, says the latest national report from England's Healthcare Safety Investigation Branch (HSIB). The report uses a reference case to demo...

Jan 10th, 2021 - (Reuters Health) - Women who receive radiotherapy for rectal cancer may be at an increased risk of uterine and ovarian cancer, a new study suggests. In an analysis of information from the SEER database on more than 20,000 female patients diagnosed...

Jun 14th, 2019 - Chemoradiotherapy (CRT) appeared to be no better than chemotherapy alone as adjuvant treatment for women with locally advanced endometrial cancer, the phase III GOG 258 trial found. At 5 years, 59% of women in the CRT arm were estimated to be aliv...

May 26th, 2019 - Among all U.S. women, rates of more aggressive non-endometrioid cancer subtypes have been rising rapidly. And trends show marked racial differences and disparities, with higher rates of uterine corpus subtypes and poorer survival among non-Hispani...

May 17th, 2019 - As many as one in eight patients with uterine cancer who undergo adjuvant radiation therapy may have been treated with doses that are inconsistent with standard practice, a new study suggests. Writing in JCO Clinical Cancer Informatics, Corbin D.